Wedbush Downgrades Lowe's (LOW) to Neutral
- Wall Street surges to new highs; transports set record
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Abbott (ABT) Files Complaint to Terminate Alere (ALR) Acquisition
- Costco Wholesale (COST) Tops Q1 EPS by 5c; Comps Up 1%, 2% Ex-Gas
- After-Hours Stock Movers 12/07: (VYGR) (LULU) (HRB( Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Wedbush downgraded Lowe's (NYSE: LOW) from Outperform to Neutral with a price target of $73.00 (from $84.00).
Analyst Seth Basham commented, " While we believe the housing cycle still has legs, the best is likely behind us. A bevy of negative data points suggest a modest slowdown in underlying home improvement sales growth ahead, while near-term trends are under more significant pressure due to weaker consumer confidence possibly associated with election uncertainty, increased promotions and tough weatherdriven comparisons. At the same time, LOW’s operational and merchandising momentum may have slowed, making it challenging to close the comp and margin gap with HD, which we believe is key for relative share price outperformance. While some of this sentiment is already reflected in LOW shares, we see more limited room for outperformance for LOW shares, leading us to downgrade our rating to NEUTRAL from OUTPERFORM, reduce our estimates below consensus and company guidance and lower our price target from $84 to $73."
Shares of Lowe's closed at $68.47 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades MGM Growth Properties (MGP) to Hold
- Cowen Downgrades Nike (NKE) to Neutral; Sees Lower Guidance
- Illumina (ILMN) Lower as Morgan Stanley Cuts Numbers, Sees Slow Growth Persisting
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!